Cannabinoid hyperemesis syndrome

Show simple item record

dc.contributor.author Elnagar, Ali
dc.contributor.author Kgomo, Mpho K.
dc.contributor.author Mokone, Modise
dc.contributor.author Yousif, Badreldin
dc.date.accessioned 2024-10-14T09:09:09Z
dc.date.available 2024-10-14T09:09:09Z
dc.date.issued 2024-04
dc.description.abstract Cannabis use is legalised in many countries. We present a patient in their 40s who complained of recurrent abdominal pain and associated nausea and vomiting. The patient was previously seen in various hospitals, treated symptomatically, and discharged with a diagnosis of non-specific abdominal pain. The patient had a chronic history of smoking cannabis and nicotine and drinking alcohol. Abdominal examination revealed no masses, and abdominal X-ray was normal. Blood tests and gastroduodenoscopy revealed no obvious aetiology. Intravenous fluids, together with antiemetics and proton pump inhibitors, were administered. The patient also received counselling and was advised to stop cannabis use. At discharge, the patient was well and asked to come back for review in 2 weeks, and, thereafter monthly for a period of 6 months after stopping cannabis use. The patient reported no recurrent symptoms despite continued cigarette and alcohol use. A suspected cannabinoid hyperemesis syndrome (CHS) became a consideration. Awareness of cannabis-related disorders such as CHS may assist in avoiding costly hospital workups. en_US
dc.description.department Internal Medicine en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.uri https://casereports.bmj.com/ en_US
dc.identifier.citation Elnagar, A., Kgomo, M., Mokone, M., et al. Cannabinoid hyperemesis syndrome. BMJ Case Reports 2024;17:e256921. doi:10.1136/bcr-2023-256921. en_US
dc.identifier.issn 1757-790X (online)
dc.identifier.other 10.1136/bcr-2023- 256921
dc.identifier.uri http://hdl.handle.net/2263/98581
dc.language.iso en en_US
dc.publisher BMJ Publishing Group en_US
dc.rights © BMJ Publishing Group Limited 2024. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license. en_US
dc.subject Cannabis en_US
dc.subject Abdominal pain en_US
dc.subject Substance use en_US
dc.subject Cannabinoid hyperemesis syndrome (CHS) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.subject Gastrointestinal system en_US
dc.subject Gastroenterology en_US
dc.subject Endoscopy en_US
dc.subject Pancreatitis en_US
dc.subject Pain en_US
dc.title Cannabinoid hyperemesis syndrome en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record